Gotowe bibliografie tematyczne / Antineoplastic agents

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Antineoplastic agents”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Antineoplastic agents”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Antineoplastic agents"

1

Carlson, Patricia A. "Antineoplastic agents." Critical Care Nursing Quarterly 18, no. 4 (1996): 1–15. http://dx.doi.org/10.1097/00002727-199602000-00002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Menta, Ernesto, and Manlio Palumbo. "Novel antineoplastic agents." Expert Opinion on Therapeutic Patents 7, no. 12 (1997): 1401–26. http://dx.doi.org/10.1517/13543776.7.12.1401.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Menta, Ernesto, and Manlio Palumbo. "Antineoplastic agents 1998." Expert Opinion on Therapeutic Patents 8, no. 12 (1998): 1627–72. http://dx.doi.org/10.1517/13543776.8.12.1627.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Pettit, G. R., Y. Kamano, R. Aoyagi, et al. "Antineoplastic agents 100." Tetrahedron 41, no. 6 (1985): 985–94. http://dx.doi.org/10.1016/s0040-4020(01)96466-x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Bukowski, Ronald M. "Novel antineoplastic agents." Current Oncology Reports 2, no. 1 (2000): 9–10. http://dx.doi.org/10.1007/s11912-000-0004-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Hong, Samuel J., Edward C. Li, Linda M. Matusiak, and Glen T. Schumock. "Spending on Antineoplastic Agents in the United States, 2011 to 2016." Journal of Oncology Practice 14, no. 11 (2018): e683-e691. http://dx.doi.org/10.1200/jop.18.00069.

Pełny tekst źródła
Streszczenie:
Purpose: Recent cancer drug approvals are lauded as being more effective with relatively fewer adverse effects, but these treatments come with a great cost to the US health care system. There is little information on recent trends in actual antineoplastic expenditures representative of the whole US health care system or by sector. Therefore, the objective of this study was to describe antineoplastic expenditures in the United States by year and sector. Methods: This was a retrospective, cross-sectional study of IQVIA (formerly QuintilesIMS) National Sales Perspective data for the period of Jan
Style APA, Harvard, Vancouver, ISO itp.
7

DOLL, DONALD C., Q. SCOT RINGENBERG, and JOHN W. YARBRO. "Antineoplastic Agents and Pregnancy." Obstetrical & Gynecological Survey 45, no. 6 (1990): 376. http://dx.doi.org/10.1097/00006254-199006000-00008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Pettit, George R., Noeleen Melody, and Jean-Charles Chapuis. "Antineoplastic Agents. 605. Isoquinstatins." Journal of Natural Products 81, no. 3 (2017): 451–57. http://dx.doi.org/10.1021/acs.jnatprod.7b00352.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hussain, M. A. ha, A. N. toinette J. Wozniak, and M. A. rk B. Edelstein. "Neurotoxicity of antineoplastic agents." Critical Reviews in Oncology/Hematology 14, no. 1 (1993): 61–75. http://dx.doi.org/10.1016/1040-8428(93)90006-p.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Castells, M. "Hypersensitivity to Antineoplastic Agents." Current Pharmaceutical Design 14, no. 27 (2008): 2892–901. http://dx.doi.org/10.2174/138161208786369803.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Antineoplastic agents"

1

Wan, Jung Wing. "Novel ether lipids as antineoplastic agents." Thesis, University of Southampton, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.242627.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Molyneux, Gemma. "Studies on the haemotoxicity of antineoplastic agents." Thesis, University College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.435080.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chen, Alina. "New polyamine analogues as potential antineoplastic agents." Scholarly Commons, 2000. https://scholarlycommons.pacific.edu/uop_etds/2680.

Pełny tekst źródła
Streszczenie:
The naturally occurring polyamines play an essential role in cell growth and proliferation. The levels of polyamines have been shown to increase in rapidly proliferating cancer cells. Therefore, compounds that inhibit enzymes in polyamine biosynthetic pathway may have therapeutic potential. Compounds capable of providing both in vitro and in vivo inhibition of almost all enzymes in the polyamine biosynthetic pathway are known. An exception is the lack of an agent that inhibits spermidine/spermine N 1 -acetyltransferase (SSAT), the rate-limiting enzyme in the catabolism of polyamines. The desig
Style APA, Harvard, Vancouver, ISO itp.
4

Ganley, Brian. "Investigations into the chemical mechanisms of biological activity by heterocyclic di-N-oxides and 1,2 benzodithiolan-3-one 1-oxides." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999285.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ramirez, Daniel A. Kane Robert R. "Synthesis of protected amino thymidines and new thiol derivatives of the vascular targeting agent combretastatin A-4." Waco, Tex. : Baylor University, 2006. http://hdl.handle.net/2104/5008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ganley, Brian Christopher. "Investigations into the chemical mechanisms of biological activity by heterocyclic di-N-oxides and 1,2 benzodithiolan-3-one 1-oxides /." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999285.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Reese, Michael. "Drug design (STAT5 modulators), development (Glyceollin I) and improvement (Esmolol Plus) /." Connect to full text in OhioLINK ETD Center, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=toledo1265033116.

Pełny tekst źródła
Streszczenie:
Thesis (M.S.)--University of Toledo, 2009.<br>Typescript. "Submitted as partial fulfillment of the requirements for the Master of Science Degree in Medicinal Chemistry." "A thesis entitled"--at head of title. Bibliography: leaves 45-48.
Style APA, Harvard, Vancouver, ISO itp.
8

Kanyanda, Stonard Sofiel Elisa. "Screening of natural products and Alkylating agents for Antineoplastic Activity." Thesis, University of the Western Cape, 2007. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_6433_1363357514.

Pełny tekst źródła
Streszczenie:
<p>Background and objectives: Apoptosis is a process in which a cell programmes its own death. It is a highly organized physiological mechanism in which injured or damaged cells are destroyed. Apart from physiological stimuli however, exogenous factors can induce apoptosis. Many anti-cancer drugs work by activating apoptosis in cancer cells. Natural substances have been found to have the ability to induce apoptosis in various tumour cells and these substances have been used as templates for the construction of&nbsp<br>novel lead compounds in anticancer treatment. On the other hand, alkylating
Style APA, Harvard, Vancouver, ISO itp.
9

Parker-, Johnson Kitani A. "An evaluation of novel antineoplastic agent on prostate cancer." DigitalCommons@Robert W. Woodruff Library, Atlanta University Center, 2003. http://digitalcommons.auctr.edu/dissertations/3074.

Pełny tekst źródła
Streszczenie:
This study examines the effects of novel antineoplastic agents(isochalcones) on human metastatic prostate cancer cell lines by screening cells for their relative antiproliferative effects, measuring the protein expression levels of specific oncogenes by Western blotting, and evaluating an array of genes ( 5184) to determine possible mechanisms of action of these novel isochalcones. The array data were supported by real-time polymerase chain reaction (PCR) techniques. The antineoplastic agents were screened in human metastatic prostate cancer cell lines (LNCaP, DU145, PC-3, and MDA-PCa-2b) and
Style APA, Harvard, Vancouver, ISO itp.
10

Lin, Tung Yin. "Synthetic studies towards the stellettins /." View online, 2008. http://repository.eiu.edu/theses/docs/32211131443971.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Antineoplastic agents"

1

Milne, George W. A., 1937-, ed. Ashgate handbook of antineoplastic agents. Ashgate, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

David, Goldman I., ed. Membrane transport of antineoplastic agents. Pergamon Press, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

1932-, Borders Donald B., and Doyle Terrence W. 1942-, eds. Enediyne antibiotics as antitumor agents. M. Dekker, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

E, Wittes Robert, and National Cancer Institute (U.S.), eds. Compilation of phase II results with single antineoplastic agents. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

V, Wilman Derry E., ed. The chemistry of antitumour agents. Blackie, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

David, Kessel, ed. Resistance to antineoplastic drugs. CRC Press, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

A, Valeriote Frederick, Corbett Thomas H, and Baker Lawrence H, eds. Anticancer drug discovery and development: Natural products and new molecular models : proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27-29, 1991. Kluwer Academic Publishers, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Chow, Nang-Ly. Liposomes as carriers of antineoplastic agents and immunomodulators. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

National Institutes of Health (U.S.), ed. Compilation of phase II results with single antineoplastic agents. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Antineoplastic agents"

1

O'brien, Wendy Pott. "Antineoplastic Agents." In Physiologically Based Pharmacokinetic Modeling. John Wiley & Sons, Inc., 2005. http://dx.doi.org/10.1002/0471478768.ch11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Patsalos, P. N. "Antineoplastic Agents." In Antiepileptic Drug Interactions. Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2434-4_57.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Patsalos, Philip N. "Antineoplastic Agents." In Antiepileptic Drug Interactions. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32909-3_61.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kirschenbaum, Harold L., and Michelle M. Kalis. "Antineoplastic Agents." In The Pharmacy Practice Handbook of Medication Facts. Routledge, 2023. http://dx.doi.org/10.4324/9780429272783-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Patsalos, Philip N. "Antineoplastic Agents." In Antiseizure Medication Interactions. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-82790-8_68.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Schmähl, D., M. R. Berger, B. K. Keppler, and T. Klenner. "New Antineoplastic Agents." In Cancer Therapy. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-74683-3_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bloch, Alexander. "Antineoplastic Agents and Cancer Cell Differentiation." In Cancer Biology and Therapeutics. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-9564-6_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Jack, David B. "Pharmacokinetic data on antineoplastic and immunosuppressant agents." In Handbook of Clinical Pharmacokinetic Data. Palgrave Macmillan UK, 1992. http://dx.doi.org/10.1007/978-1-349-22495-1_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Balis, Frank M. "The pharmacology of antineoplastic agents in children." In The Role of Pharmacology in Pediatric Oncology. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-4267-7_2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Berger, Martin R. "Experiments on the Carcinogenic Potential of Antineoplastic Agents." In Late Sequelae in Oncology. Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-46794-3_34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Antineoplastic agents"

1

Alonso Castro, V., B. López Centeno, I. Martín Casasempere, et al. "4CPS-105 Prescribed antineoplastic agents in paediatric patients." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.254.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Yoon, Seug Yun, Namsu Lee, Sook-Ja Kim, Hee-Jeong Cheong, Kyoung Ha Kim, and Jong-Ho Won. "Abstract 3843: Pulmonary toxicities of molecular targeted antineoplastic agents." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3843.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Labrèche, F., B. Roberge, A. Yennek, NJ Caron, and J.-F. Bussières. "1508 Is hospital sanitation personnel exposed to antineoplastic agents?" In 32nd Triennial Congress of the International Commission on Occupational Health (ICOH), Dublin, Ireland, 29th April to 4th May 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/oemed-2018-icohabstracts.923.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Silva, Sâmela Maria de Oliveira, Manuelle de Araujo Holanda, Thaísa Mirella da Silva, Clebiana Alves e. silva Diniz, and Suzana Maria de Oliveira Costa Meneses. "Role of oncological nursing in stroke of antineoplastic drugs." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-044.

Pełny tekst źródła
Streszczenie:
Abstract Exposure to antineoplastic drugs poses a potential risk to the health of professionals who handle, administer and dispose of them. The risk of harmful effects arising from exposure to the cytotoxic properties of antineoplastic agents is not restricted to patients, and health professionals may also experience cellular and clinical changes related to occupational exposure to these substances. Professional exposure can occur at any time during the handling of chemotherapy, whether in preparation, administration or disposal.
Style APA, Harvard, Vancouver, ISO itp.
5

Bradley, Cathy J., and Marcelo Coca Perraillon. "Abstract PR10: Fewer rural cancer patients treated with antineoplastic agents." In Abstracts: Eleventh AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 2-5, 2018; New Orleans, LA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp18-pr10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Trendowski, Matthew, Timothy D. Christen, Christopher Acquafondata, and Thomas P. Fondy. "Abstract 3802: Evaluation of microfilament-directed cytochalasins as novel antineoplastic agents." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3802.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Escudero-Vilaplana, V., R. Collado-Borrell, A. Giménez-Manzorro, et al. "CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.162.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Kulemina, Lidia V., Kevin Morgan, Daniil Shabashvili, Carmen Allegra, Min Chen, and Maria Zajac-Kaye. "Abstract 3892: Anti-cooperative allosteric inhibitors of thymidylate synthase as novel antineoplastic agents." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3892.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Narrillos-Moraza, A., V. Escudero-Vilaplana, R. Collado-Borrell, et al. "5PSQ-048 Analysis of drug interactions between oral antineoplastic agents and concurrent medications." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.365.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Rodriguez, A., X. Fernández, A. Arderiu, et al. "1ISG-003 Impact of telepharmacy and community pharmacy remote-dispensing on patients on oral antineoplastic agents." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Antineoplastic agents"

1

Antineoplastic agents - occupational hazards in hospitals. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2004. http://dx.doi.org/10.26616/nioshpub2004102.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Antineoplastic agents” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii